Difference between zometa and reclast. Zoledronic Acid: Understanding Zometa and Reclast for Bone Health in Cancer Patients
What are the key differences between Zometa and Reclast. How does zoledronic acid work to slow bone destruction in cancer patients. What are the potential side effects of zoledronic acid treatment. How is zoledronic acid administered and what precautions should patients take.
What is Zoledronic Acid and How Does it Work?
Zoledronic acid is a powerful medication classified as a bisphosphonate. Its primary function is to slow down the destruction of bone caused by cancer cells. This is particularly crucial for patients with certain types of cancers that commonly spread to the bones, such as breast, prostate, and lung cancers. Additionally, it plays a significant role in treating multiple myeloma, a cancer affecting plasma cells in the bone marrow.
How does zoledronic acid achieve this bone-protective effect? The medication works by inhibiting the activity of osteoclasts, the cells responsible for breaking down bone tissue. By doing so, it helps maintain bone density and strength, reducing the risk of fractures and alleviating bone pain in cancer patients.
The Impact of Cancer on Bone Health
When cancer spreads to the bones or directly affects bone marrow, as in multiple myeloma, it can cause significant damage to the skeletal structure. This process, known as bone metastasis, leads to:
- Weakening of the bone structure
- Increased risk of fractures
- Chronic bone pain
- Hypercalcemia (elevated calcium levels in the blood)
Zoledronic acid addresses these issues by interfering with the bone breakdown process, thereby helping to maintain bone integrity and reduce associated complications.
Zometa vs Reclast: Unraveling the Differences
While both Zometa and Reclast contain zoledronic acid as their active ingredient, they are used for different purposes and have distinct dosing regimens. What sets these two medications apart?
Zometa: Tailored for Cancer-Related Bone Issues
Zometa is specifically formulated to address bone-related complications in cancer patients. It is commonly prescribed for:
- Preventing skeletal-related events in patients with bone metastases
- Treating hypercalcemia of malignancy
- Managing bone lesions in multiple myeloma
The typical dosing for Zometa is 4 mg administered intravenously every 3-4 weeks, though this can vary based on the patient’s specific condition and treatment plan.
Reclast: Focused on Osteoporosis Management
Reclast, on the other hand, is primarily used for the treatment and prevention of osteoporosis. Its applications include:
- Treating postmenopausal osteoporosis
- Increasing bone mass in men with osteoporosis
- Treating and preventing glucocorticoid-induced osteoporosis
- Treating Paget’s disease of bone
Reclast is typically administered as a once-yearly 5 mg intravenous infusion for osteoporosis treatment, or once every two years for osteoporosis prevention.
Administration and Dosing: How is Zoledronic Acid Given?
Zoledronic acid, whether in the form of Zometa or Reclast, is administered intravenously. This method ensures that the medication is delivered directly into the bloodstream, maximizing its effectiveness. How does the administration process work?
- Pre-infusion assessment: Before receiving the medication, patients undergo blood tests to check kidney function and calcium levels.
- Hydration: Patients are often advised to drink plenty of fluids before and after the infusion to support kidney function.
- Infusion: The medication is given through an IV line over a period of 15-30 minutes.
- Post-infusion monitoring: Patients are typically observed for a short period after the infusion to ensure there are no immediate adverse reactions.
Is the dosing the same for all patients? No, the dose and frequency of zoledronic acid administration can vary based on several factors:
- The specific condition being treated (cancer-related bone issues vs. osteoporosis)
- The patient’s kidney function
- The patient’s overall health status
- The presence of any side effects from previous treatments
Healthcare providers carefully determine the appropriate dosing regimen for each individual patient to ensure optimal effectiveness while minimizing the risk of side effects.
Potential Side Effects: What to Watch For
Like all medications, zoledronic acid can cause side effects. While many patients tolerate the treatment well, it’s crucial to be aware of potential adverse reactions. What are the most common side effects of zoledronic acid?
Common Side Effects
- Flu-like symptoms (fever, chills, body aches)
- Fatigue
- Nausea and vomiting
- Bone, joint, and muscle pain
- Headache
- Dizziness
These symptoms are often mild and tend to improve over time. However, patients should report persistent or severe symptoms to their healthcare provider.
Serious Side Effects Requiring Immediate Attention
While less common, some side effects of zoledronic acid can be serious and require prompt medical attention. These include:
- Osteonecrosis of the jaw (ONJ)
- Atypical femur fractures
- Severe kidney problems
- Hypocalcemia (low blood calcium levels)
- Severe allergic reactions
Patients should be educated about these potential complications and instructed to seek medical help immediately if they experience symptoms such as jaw pain, unusual thigh or groin pain, or signs of allergic reaction like difficulty breathing or swelling of the face and throat.
Managing Side Effects: Strategies for Patient Comfort
While side effects can be concerning, there are several strategies that can help manage them effectively. How can patients cope with the potential side effects of zoledronic acid?
Nausea and Vomiting
To combat nausea and vomiting, patients can:
- Take anti-nausea medications as prescribed by their doctor
- Eat small, frequent meals instead of large ones
- Avoid greasy, spicy, or acidic foods
- Stay hydrated with clear fluids
- Try ginger-based products, which can have a natural anti-nausea effect
Bone, Joint, and Muscle Pain
For managing pain, patients might consider:
- Using over-the-counter pain relievers as recommended by their healthcare provider
- Applying heat or cold packs to affected areas
- Engaging in gentle stretching or low-impact exercises
- Practicing relaxation techniques such as deep breathing or meditation
Fatigue
To combat fatigue, patients can:
- Maintain a regular sleep schedule
- Engage in light exercise, such as short walks
- Prioritize activities and take breaks as needed
- Consider complementary therapies like acupuncture or yoga
It’s important for patients to communicate openly with their healthcare team about any side effects they experience. This allows for prompt intervention and adjustment of the treatment plan if necessary.
Precautions and Considerations: Ensuring Safe Treatment
While zoledronic acid can be highly beneficial for many patients, certain precautions need to be taken to ensure safe and effective treatment. What should patients and healthcare providers keep in mind?
Kidney Function Monitoring
Zoledronic acid can potentially impact kidney function. Therefore:
- Patients should undergo regular kidney function tests before and during treatment
- The medication dose may need to be adjusted or treatment paused if kidney function declines
- Adequate hydration is crucial before and after each infusion
Dental Health Considerations
Due to the risk of osteonecrosis of the jaw (ONJ), dental health is a key concern:
- Patients should have a comprehensive dental exam before starting treatment
- Invasive dental procedures should be avoided during treatment if possible
- Good oral hygiene practices are essential
- Any dental issues should be promptly reported to both the dentist and the prescribing physician
Calcium and Vitamin D Supplementation
To support bone health and prevent hypocalcemia:
- Patients are often prescribed calcium and vitamin D supplements
- Regular monitoring of calcium levels is important
- Patients should adhere to the recommended supplementation regimen
Pregnancy and Breastfeeding
Zoledronic acid is not recommended during pregnancy or breastfeeding:
- Women of childbearing age should use effective contraception during treatment
- Pregnant women should not receive zoledronic acid unless absolutely necessary
- Breastfeeding is not advised during treatment due to potential risks to the infant
By adhering to these precautions and maintaining open communication with their healthcare team, patients can maximize the benefits of zoledronic acid treatment while minimizing potential risks.
Long-Term Outlook: Benefits and Considerations
Zoledronic acid treatment can offer significant benefits for patients with cancer-related bone issues or osteoporosis. However, it’s important to consider both the short-term and long-term implications of this therapy. What can patients expect in terms of long-term outcomes and considerations?
Positive Outcomes
For many patients, the long-term benefits of zoledronic acid treatment can be substantial:
- Reduced risk of skeletal-related events in cancer patients
- Improved bone density and reduced fracture risk in osteoporosis patients
- Better pain management for those with bone metastases
- Potential improvement in overall quality of life
Long-Term Considerations
While the benefits are significant, there are some long-term considerations to keep in mind:
- The optimal duration of treatment is still a subject of ongoing research
- Some patients may need to take drug holidays to reduce the risk of certain side effects
- Regular monitoring of bone health and kidney function is necessary throughout treatment
- The risk of rare but serious side effects like ONJ and atypical fractures may increase with long-term use
Patients should engage in ongoing discussions with their healthcare providers about the benefits and risks of continued treatment, especially as their health status or treatment goals may change over time.
Future Directions in Research
The field of bone health in cancer and osteoporosis treatment continues to evolve. Current areas of research include:
- Optimizing treatment schedules to maximize benefits while minimizing side effects
- Investigating combination therapies with other bone-modifying agents
- Exploring the potential preventive effects of zoledronic acid in early-stage cancers
- Developing strategies to mitigate the risk of rare but serious side effects
As research progresses, treatment protocols may be refined, potentially leading to even better outcomes for patients in the future.
In conclusion, zoledronic acid, whether in the form of Zometa or Reclast, plays a crucial role in managing bone health for cancer patients and those with osteoporosis. While the medication offers significant benefits, it’s essential for patients and healthcare providers to weigh these against potential risks and side effects. Through careful monitoring, adherence to precautions, and open communication, patients can maximize the therapeutic benefits of zoledronic acid while minimizing potential complications. As research continues to advance our understanding of this powerful medication, we can look forward to even more refined and effective treatment strategies in the years to come.
Zoledronic Acid (Zometa®, Reclast®) | OncoLink
Author: Karen Arnold-Korzeniowski, BSN RN
Read more about our content writing process
Last Reviewed:
Pronounced: ZOE-le-DRON-ik AS-id
Classification: bisphosphonate
About: Zoledronic Acid (Zometa®, Reclast®)
Zoledronic acid is a type of medication called a bisphosphonate, which is used to slow the destruction of bone caused by cancer cells. Cancer cells from some tumors (most commonly breast, prostate and lung cancers) can spread to the bone, which is called bone metastasis. Multiple myeloma is a type of cancer affecting plasma cells, which are found in the bone marrow, and thus directly involves bone. In both of these situations, the cancer cells cause breakdown or wearing away of normal bone. In turn, affected bones become more fragile; they may be painful and can even break due to the damage from the cancer cells.
How to Take Zoledronic Acid
Zoledronic acid is administered intravenously (IV, into a vein). Your dose, and how often you receive it, will be determined by your provider. Your healthcare provider may prescribe you calcium and vitamin D supplements to promote bone health.
You will have lab work done to monitor your electrolytes during treatment. Your creatinine level (indicator of your kidney function) will be monitored closely to determine if the medication is affecting your kidneys. If it is, the dose may be altered or the medication stopped completely.
Possible Side Effects of Zoledronic Acid
There are a number of things you can do to manage the side effects of zoledronic acid. Talk to your care team about these recommendations. They can help you decide what will work best for you. These are some of the most common or important side effects:
Nausea and/or Vomiting
Talk to your doctor or nurse so they can prescribe medications to help you manage nausea and vomiting.
In addition, dietary changes may help. Avoid things that may worsen the symptoms, such as heavy or greasy/fatty, spicy or acidic foods (lemons, tomatoes, oranges). Try antacids, (e.g. milk of magnesia, calcium tablets such as Tums), saltines, or ginger ale to lessen symptoms.
Call your doctor or nurse if you are unable to keep fluids down for more than 12 hours or if you feel lightheaded or dizzy at any time.
Low Red Blood Cell Count (Anemia)
Your red blood cells are responsible for carrying oxygen to the tissues in your body. When the red cell count is low, you may feel tired or weak. You should let your oncology care team know if you experience any shortness of breath, difficulty breathing or pain in your chest. If the count gets too low, you may receive a blood transfusion.
Bone, Joint, and Muscle Pain
Zoledronic acid can cause bone, joint and/or muscle pain that can be severe.
This can occur from 1 day to several months after starting the medication. Report these symptoms to your provider, who can advise you on strategies to relieve the pain. Pain in the hip, thigh, and groin can be caused by an atypical femur fracture. Notify your provider immediately of any new pain in this area.
Fatigue
Fatigue is very common during cancer treatment and is an overwhelming feeling of exhaustion that is not usually relieved by rest. While on cancer treatment, and for a period after, you may need to adjust your schedule to manage fatigue. Plan times to rest during the day and conserve energy for more important activities. Exercise can help combat fatigue; a simple daily walk with a friend can help. Talk to your healthcare team for helpful tips on dealing with this side effect.
Breathing Difficulties
Bronchoconstriction is the constriction of the lung airways caused by muscle tightening. Patients who are sensitive to aspirin may have bronchoconstriction related to zoledronic acid.
Notify your provider of any trouble breathing, tightness in the chest or wheezing.
Less common but important side effects can include:
- Osteonecrosis of the Jaw: Osteonecrosis of the jaw (ONJ) is a rare side effect, however, it is important that you know about it and take steps to protect your dental health. The maxilla (upper jaw bone) and mandible (lower jaw bone) are normally covered by gum tissue. In the case of ONJ, this tissue disappears and the bone is exposed. Typical symptoms associated with ONJ are: pain, swelling or infection of the gums, loosening of the teeth, exposed bone (often at the site of a previous tooth extraction). Some patients may report numbness or tingling in the jaw or a “heavy” feeling jaw. ONJ may have no symptoms for weeks or months and may only be recognized by the presence of exposed bone. ONJ most often occurs soon after a dental procedure, though not always.
Stop treatment with zoledronic acid at least 3 weeks prior to any dental procedures.- Prior to starting therapy, you should have a complete dental exam, cleaning, and removal of any teeth in poor health.
- Dentures should be checked for proper fit.
- Brush your teeth after meals and at bedtime with a soft brush. Floss gently once a day. If your gums bleed, talk with your healthcare team to see if you can continue to floss.
- Check your teeth and gums in a mirror daily for any sores, swelling, loose teeth, pain or numbness, or other changes and report these to your dentist or oncology team immediately.
- Acute Reaction: The infusion can cause a reaction that occurs within 3 days of the infusion and may cause chills, fever and muscle aches. Prior to taking any medications, check with your healthcare provider as these can also be signs of infection. If you are able to take anti-inflammatory medications, such as ibuprofen (Motrin) and naproxen (Aleve), they may be helpful in treating these side effects. Reactions are most common during or shortly after the first infusion, but not after subsequent doses.
- Kidney problems: This medication can cause kidney problems, including an increased creatinine level, which your oncology care team may monitor for using blood tests. Notify your healthcare provider if you notice decreased urine output, blood in the urine, swelling in the ankles, or loss of appetite.
- Hypocalcemia: This medication can lower your calcium levels. Your healthcare team will monitor your calcium levels with blood tests. If you experience muscle cramps or confusion, contact your healthcare team.
Stop treatment with zoledronic acid at least 3 weeks prior to any dental procedures.
Reactions are most common during or shortly after the first infusion, but not after subsequent doses.Reproductive Concerns
Exposure of an unborn child to this medication could cause birth defects, so you should not become pregnant or father a child while on this medication. Effective birth control is necessary during treatment. Even if your menstrual cycle stops or you believe you are not producing sperm, you could still be fertile and conceive.
You should consult with your healthcare team before breastfeeding while receiving this medication.
Aclasta vs Zometa Comparison – Drugs.com
Aclasta vs Zometa Comparison – Drugs.com
Skip to main content
Enter another drug to compare |
|---|
Related suggestions Osteoporosis
Osteolytic Bone Metastases of Solid Tumors
Hypercalcemia of Malignancy
Osteolytic Bone Lesions of Multiple Myeloma
| ||
| More about Aclasta (zoledronic acid) | More about Zometa (zoledronic acid) | |
| Generic Status | ||
Lower-cost generic is available | Lower-cost generic is available | |
| Ratings & Reviews | ||
Aclasta has an average rating of | Zometa has an average rating of | |
View all 27 reviews | View all 41 reviews | |
| Drug Class | ||
|
| |
| Side Effects | ||
See also: Aclasta side effects in more detail. | Common side effects include:
See also: Zometa side effects in more detail. | |
| Pricing and Coupons * Prices are without insurance | ||
We could not find an exact match for this medicine. Try searching the Price Guide directly. | We could not find an exact match for this medicine. Try searching the Price Guide directly. | |
Get free Discount Card | Get free Discount Card | |
| Dosage Form(s) Available | ||
N/A |
| |
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value.  | ||
N/A | N/A | |
| CSA Schedule ** View glossary of terms | ||
Is not subject to the Controlled Substances Act. | Is not subject to the Controlled Substances Act. | |
| Pregnancy Category | ||
See the full pregnancy warnings document. | See the full pregnancy warnings document. | |
| Drug Interactions | ||
A total of 118 drugs are known to interact with Aclasta:
| A total of 118 drugs are known to interact with Zometa:
| |
| Alcohol/Food/Lifestyle Interactions | ||
No known alcohol/food interactions. | No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. | |
| Disease Interactions | ||
|
| |
| First Approval Date | ||
N/A | February 22, 2002 | |
| WADA Class View World Anti-Doping Agency classifications.  | ||
N/A | N/A | |
| More Information | ||
|
| |
| Patient resources | ||
|
| |
| Professional Resources | ||
N/A |
| |
</p>
<p>
Aclasta may also be used for purposes not listed in this comparison guide.
</p>
”>
It must be administered over no less than 15 minutes.</p>
<p>
Prescribed for Osteoporosis, Paget’s Disease, Osteolytic Bone Lesions of Multiple Myeloma, Osteolytic Bone Metastases of Solid Tumors, Hypercalcemia of Malignancy.
</p>
<p>
Zometa may also be used for purposes not listed in this comparison guide.
</p>
”>
..
1 out of 10 from a total of
This does not necessarily mean no interactions exist. Always consult your healthcare provider.** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law.